300 related articles for article (PubMed ID: 8667082)
1. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
Schmidt KC; Lucignani G; Sokoloff L
J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
[No Abstract] [Full Text] [Related]
2. Simplified calculation of MRglc using PET.
Phillips RL; London ED
J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
[No Abstract] [Full Text] [Related]
3. [Tomographic measurement of human cerebral glucose metabolism].
Iwasaki Y; Konishi J; Makada Y; Yonekura Y
Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
[No Abstract] [Full Text] [Related]
4. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
Alavi A; Smith R; Duncan D
J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
[No Abstract] [Full Text] [Related]
5. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study.
Miura SA; Schapiro MB; Grady CL; Kumar A; Salerno JA; Kozachuk WE; Wagner E; Rapoport SI; Horwitz B
J Neurosci Res; 1990 Dec; 27(4):500-4. PubMed ID: 2079712
[TBL] [Abstract][Full Text] [Related]
6. [Functional brain study by radionuclide neuroimaging].
Uemura K
No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
[No Abstract] [Full Text] [Related]
7. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
8. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
Tamminga CA
Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
[No Abstract] [Full Text] [Related]
9. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
Kuwabara H; Gjedde A
J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
[TBL] [Abstract][Full Text] [Related]
10. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Arahata Y; Kato T; Tadokoro M; Sobue G
Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
[TBL] [Abstract][Full Text] [Related]
11. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.
Rottenberg DA; Moeller JR; Strother SC; Dhawan V; Sergi ML
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A83-8. PubMed ID: 1997493
[TBL] [Abstract][Full Text] [Related]
12. Clarification of a fractional uptake concept.
Thie JA
J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
[No Abstract] [Full Text] [Related]
13. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.
Pawlik G; Wienhard K; Herholz K; Wagner R; Heiss WD
Prog Brain Res; 1984; 62():253-62. PubMed ID: 6335919
[No Abstract] [Full Text] [Related]
14. Functional brain imaging in 200 patients after whiplash injury.
Otte A; Mueller-Brand J; Nitzsche EU; Wachter K; Ettlin TM
J Nucl Med; 1997 Jun; 38(6):1002. PubMed ID: 9189162
[No Abstract] [Full Text] [Related]
15. Emission computed tomography in the study of human epilepsy.
Kuhl DE; Engel J; Phelps ME
Res Publ Assoc Res Nerv Ment Dis; 1983; 61():327-40. PubMed ID: 6601815
[No Abstract] [Full Text] [Related]
16. Program for PET image alignment: effects on calculated differences in cerebral metabolic rates for glucose.
Phillips RL; London ED; Links JM; Cascella NG
J Nucl Med; 1990 Dec; 31(12):2052-7. PubMed ID: 2266408
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F
Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724
[No Abstract] [Full Text] [Related]
18. Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?
Azari NP; Pietrini P
J Neurol; 1995 Jan; 242(2):112-4. PubMed ID: 7707087
[No Abstract] [Full Text] [Related]
19. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG.
Suhonen-Polvi H; Ruotsalainen U; Ahonen A; Haaparanta M; Aho K; Riikonen R; Kero P; Korvenranta H; Simell O; Wegelius U
Acta Radiol Suppl; 1991; 376():173. PubMed ID: 1666770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
